BIO.B
Bio-Rad Laboratories B·NYSE
--
--(--)
--
--(--)
Bio-Rad Laboratories B (BIO.B) Revenue Breakdown
Bio-Rad Laboratories B (BIO.B) Revenue Breakdown: Q3 2025 Business & Regional Performance
Bio-Rad Laboratories B (BIO.B) reported total revenue of 653.00M USD in Q3 2025, with its core business segment Life Science contributing 40.09%. Regionally, United States remained the largest market, accounting for 39.25% of total revenue. Explore Bio-Rad Laboratories B's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Bio-Rad Laboratories B (BIO.B) reported total revenue of 653.00M USD in Q3 2025, with its core business segment Life Science contributing 40.09%. Regionally, United States remained the largest market, accounting for 39.25% of total revenue. Explore Bio-Rad Laboratories B's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What guidance did Bio-Rad Laboratories B's management provide for the next earnings period?What is Bio-Rad Laboratories B's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Bio-Rad Laboratories B year over year?Did Bio-Rad Laboratories B beat or miss consensus estimates last quarter?What does Bio-Rad Laboratories B do and what are its main business segments?What factors drove the changes in Bio-Rad Laboratories B's revenue and profit?What is Bio-Rad Laboratories B's gross profit margin?What is the market's earnings forecast for Bio-Rad Laboratories B next quarter?
